Loading...
Header Logo
Keywords
Last Name
KP Region

Jessica Chubak, PhD, MBHL

TitleAssociate Investigator
InstitutionKaiser Permanente Washington
DepartmentHealth Research Institute
ORCID ORCID Icon 0000-0003-1630-9021 Additional info
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Jessica Chubak, PhD, is an epidemiologist who works to improve cancer diagnosis, treatment, control, and survivorship. She contributes to several national collaborations that are finding practical, efficient, effective ways to screen for cancer, especially colorectal cancer. She also studies how common medications affect cancer risk and recurrence. Based on a personal interest in how pets positively affect health, Dr. Chubak is studying animal-assisted activities in clinics and hospitals where children get treated for cancer. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data in epidemiologic and health services studies. She is the Kaiser Permanente Washington Health Research Institute (KPWHRI) principal investigator for the National Cancer Institute's Cancer Research Network.

    Dr. Chubak joined KPWHRI in 2007, bringing expertise in epidemiologic methods, pharmacoepidemiology, and cancer. Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand before completing her PhD in Epidemiology at the University of Washington. Dr. Chubak is an affiliate associate professor in the Department of Epidemiology at the University of Washington School of Public Health where she enjoys guest lecturing and getting to work with students.

    Collapse Research 
    Collapse research activities and funding
    R21CA143242     (CHUBAK, JESSICA)Jan 4, 2010 - Jun 30, 2012
    NIH/NCI
    Algorithms to Identify Second Breast Cancer Events from Electronic Data
    Role: Principal Investigator

    R03CA156357     (CHUBAK, JESSICA)Sep 1, 2011 - Aug 31, 2012
    NIH/NCI
    Risk of Non-Hodgkin's Lymphoma in Relation to Tricyclic Antidepressant Use
    Role: Principal Investigator

    U54CA163261     (CHUBAK, JESSICA)Sep 1, 2011 - May 31, 2018
    NIH/NCI
    Studying Colorectal Cancer Effectiveness of Screening Strategies (SuCCESS)
    Role: Principal Investigator

    R03CA169576     (CHUBAK, JESSICA)Apr 1, 2013 - Mar 31, 2015
    NIH/NCI
    Developing trials of animal-assisted activities for youth with cancer
    Role: Principal Investigator

    R01CA172073     (CHUBAK, JESSICA)Sep 19, 2013 - Jul 31, 2017
    NIH/NCI
    Commonly Used Medications and Risk of Colorectal Cancer Recurrence
    Role: Principal Investigator

    R21HD091877     (CHUBAK, JESSICA)May 1, 2017 - Apr 30, 2019
    NIH/NICHD
    Psychological benefits and potential pathogen transmission in hospitalized pediatric oncology patients receiving therapy dog visits: a randomized controlled trial
    Role: Principal Investigator

    UG3CA218909     (ETZIONI, RUTH D)Sep 25, 2017 - Aug 31, 2019
    NIH/NCI
    ReCAPSE: Recurrence from Claims And PROs for SEER Enhancement
    Role: Co-Principal Investigator

    UM1CA222035     (CORLEY, DOUGLAS ALLEN)Apr 15, 2018 - Mar 31, 2023
    NIH/NCI
    Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE)
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Chubak J, McLerran D, Zheng Y, Singal AG, Corley DA, Doria-Rose VP, Doubeni CA, Kamineni A, Haas JS, Halm EA, Skinner CS, Zauber AG, Wernli KJ, Beaber EF. Receipt of Colonoscopy Following Diagnosis of Advanced Adenomas: An Analysis within Integrated Healthcare Delivery Systems. Cancer Epidemiol Biomarkers Prev. 2018 Nov 20. PMID: 30459208.
      View in: PubMed
    2. Chen Y, Wang J, Chubak J, Hubbard RA. Inflation of type I error rates due to differential misclassification in EHR-derived outcomes: Empirical illustration using breast cancer recurrence. Pharmacoepidemiol Drug Saf. 2018 Oct 30. PMID: 30375122.
      View in: PubMed
    3. Kamineni A, Tiro JA, Beaber EF, Silverberg MJ, Wheeler CM, Chao CR, Chubak J, Skinner CS, Corley DA, Kim JJ, Balasubramanian BA, Doria-Rose VP. Cervical Cancer Screening Research in the PROSPR I Consortium: Rationale, Methods, and Baseline Findings from a U.S. Cohort. Int J Cancer. 2018 Oct 24. PMID: 30353911.
      View in: PubMed
    4. Chubak J, Yu O, Ziebell RA, Bowles EJA, Sterrett AT, Fujii MM, Boggs JM, Burnett-Hartman AN, Boudreau DM, Chen L, Floyd JS, Ritzwoller DP, Hubbard RA. Risk of colon cancer recurrence in relation to diabetes. Cancer Causes Control. 2018 Nov; 29(11):1093-1103. PMID: 30244297.
      View in: PubMed
    5. Selby K, Jensen CD, Lee JK, Doubeni CA, Schottinger JE, Zhao WK, Chubak J, Halm E, Ghai NR, Contreras R, Skinner C, Kamineni A, Levin TR, Corley DA. Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection: A Community-Based Cohort Study. Ann Intern Med. 2018 Oct 02; 169(7):439-447. PMID: 30242328.
      View in: PubMed
    6. Jones SMW, Walker R, Fujii M, Nekhlyudov L, Rabin BA, Chubak J. Financial difficulty, worry about affording care, and benefit finding in long-term survivors of cancer. Psychooncology. 2018 Apr; 27(4):1320-1326. PMID: 29462511.
      View in: PubMed
    7. Singal AG, Corley DA, Kamineni A, Garcia M, Zheng Y, Doria-Rose PV, Quinn VP, Jensen CD, Chubak J, Tiro J, Doubeni CA, Ghai NR, Skinner CS, Wernli K, Halm EA. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States. Am J Gastroenterol. 2018 May; 113(5):746-754. PMID: 29487413.
      View in: PubMed
    8. Chubak J, Onega T, Zhu W, Buist DSM, Hubbard RA. An Electronic Health Record-based Algorithm to Ascertain the Date of Second Breast Cancer Events. Med Care. 2017 12; 55(12):e81-e87. PMID: 29135770.
      View in: PubMed
    9. Chen L, Chubak J, Boudreau DM, Barlow WE, Weiss NS, Li CI. Diabetes Treatments and Risks of Adverse Breast Cancer Outcomes among Early-Stage Breast Cancer Patients: A SEER-Medicare Analysis. Cancer Res. 2017 11 01; 77(21):6033-6041. PMID: 28935814.
      View in: PubMed
    10. Chen L, Chubak J, Boudreau DM, Barlow WE, Weiss NS, Li CI. Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER-Medicare Population. Cancer Epidemiol Biomarkers Prev. 2017 11; 26(11):1603-1610. PMID: 28807926.
      View in: PubMed
    11. Singal AG, Tiro J, Li X, Adams-Huet B, Chubak J. Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System. J Clin Gastroenterol. 2017 Aug; 51(7):650-655. PMID: 27870642.
      View in: PubMed
    12. Green BB, Anderson ML, Cook AJ, Chubak J, Fuller S, Meenan RT, Vernon SW. A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial. Cancer. 2017 Nov 15; 123(22):4472-4480. PMID: 28753230.
      View in: PubMed
    13. Chubak J, Hawkes R, Dudzik C, Foose-Foster JM, Eaton L, Johnson RH, Macpherson CF. Pilot Study of Therapy Dog Visits for Inpatient Youth With Cancer. J Pediatr Oncol Nurs. 2017 Sep/Oct; 34(5):331-341. PMID: 28614971.
      View in: PubMed
    14. Reed SC, Walker R, Ziebell R, Rabin B, Nutt S, Chubak J, Nekhlyudov L. Cancer Survivors' Reported Discussions with Health Care Providers About Follow-Up Care and Receipt of Written Care Plans. J Cancer Educ. 2017 May 08. PMID: 28480500.
      View in: PubMed
    15. Hardikar S, Burnett-Hartman AN, Chubak J, Upton MP, Zhu LC, Potter JD, Newcomb PA. Reproductive factors and risk of colorectal polyps in a colonoscopy-based study in western Washington State. Cancer Causes Control. 2017 03; 28(3):241-246. PMID: 28205046.
      View in: PubMed
    16. Jones SM, Ziebell R, Walker R, Nekhlyudov L, Rabin BA, Nutt S, Fujii M, Chubak J. Association of worry about cancer to benefit finding and functioning in long-term cancer survivors. Support Care Cancer. 2017 05; 25(5):1417-1422. PMID: 27981365.
      View in: PubMed
    17. Shortreed SM, Johnson E, Rutter CM, Kamineni A, Wernli KJ, Chubak J. Cohort restriction based on prior enrollment: Examining potential biases in estimating cancer and mortality risk. Obs Stud. 2016 Aug; 2:51-64. PMID: 28530002.
      View in: PubMed
    18. Chubak J, Ziebell R, Greenlee RT, Honda S, Hornbrook MC, Epstein M, Nekhlyudov L, Pawloski PA, Ritzwoller DP, Ghai NR, Feigelson HS, Clancy HA, Doria-Rose VP, Kushi LH. The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations. Cancer Causes Control. 2016 11; 27(11):1315-1323. PMID: 27639398.
      View in: PubMed
    19. Drescher CW, Beatty JD, Resta R, Andersen MR, Watabayashi K, Thorpe J, Hawley S, Purkey H, Chubak J, Hanson N, Buist DSM, Urban N. The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial. Cancer. 2016 Nov 15; 122(22):3509-3518. PMID: 27447168.
      View in: PubMed
    20. Klabunde CN, Zheng Y, Quinn VP, Beaber EF, Rutter CM, Halm EA, Chubak J, Doubeni CA, Haas JS, Kamineni A, Schapira MM, Vacek PM, Garcia MP, Corley DA. Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly. Am J Prev Med. 2016 09; 51(3):e67-75. PMID: 27344108.
      View in: PubMed
    21. Nekhlyudov L, Walker R, Ziebell R, Rabin B, Nutt S, Chubak J. Cancer survivors' experiences with insurance, finances, and employment: results from a multisite study. J Cancer Surviv. 2016 12; 10(6):1104-1111. PMID: 27277896.
      View in: PubMed
    22. Halm EA, Beaber EF, McLerran D, Chubak J, Corley DA, Rutter CM, Doubeni CA, Haas JS, Balasubramanian BA. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach. J Gen Intern Med. 2016 10; 31(10):1190-7. PMID: 27279097.
      View in: PubMed
    23. Hubbard RA, Johnson E, Chubak J, Wernli KJ, Kamineni A, Bogart A, Rutter CM. Accounting for misclassification in electronic health records-derived exposures using generalized linear finite mixture models. Health Serv Outcomes Res Methodol. 2017 Jun; 17(2):101-112. PMID: 28943779.
      View in: PubMed
    24. McCarthy AM, Kim JJ, Beaber EF, Zheng Y, Burnett-Hartman A, Chubak J, Ghai NR, McLerran D, Breen N, Conant EF, Geller BM, Green BB, Klabunde CN, Inrig S, Skinner CS, Quinn VP, Haas JS, Schnall M, Rutter CM, Barlow WE, Corley DA, Armstrong K, Doubeni CA. Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity. Am J Prev Med. 2016 10; 51(4):507-12. PMID: 27132628.
      View in: PubMed
    25. Chubak J, Whitlock EP, Williams SB, Kamineni A, Burda BU, Buist DS, Anderson ML. Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force. Ann Intern Med. 2016 Jun 21; 164(12):814-25. PMID: 27064482.
      View in: PubMed
    26. Burnett-Hartman AN, Mehta SJ, Zheng Y, Ghai NR, McLerran DF, Chubak J, Quinn VP, Skinner CS, Corley DA, Inadomi JM, Doubeni CA. Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems. Am J Prev Med. 2016 10; 51(4):e107-15. PMID: 27050413.
      View in: PubMed
    27. Chubak J, Hubbard R. Defining and measuring adherence to cancer screening. J Med Screen. 2016 12; 23(4):179-185. PMID: 26946420.
      View in: PubMed
    28. Green BB, Anderson ML, Chubak J, Baldwin LM, Tuzzio L, Catz S, Cole A, Vernon SW. Colorectal Cancer Screening Rates Increased after Exposure to the Patient-Centered Medical Home (PCMH). J Am Board Fam Med. 2016 Mar-Apr; 29(2):191-200. PMID: 26957375; PMCID: PMC4868497.
    29. Chubak J, Garcia MP, Burnett-Hartman AN, Zheng Y, Corley DA, Halm EA, Singal AG, Klabunde CN, Doubeni CA, Kamineni A, Levin TR, Schottinger JE, Green BB, Quinn VP, Rutter CM. Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems. Cancer Epidemiol Biomarkers Prev. 2016 Feb; 25(2):344-50. PMID: 26843520; PMCID: PMC4767632 [Available on 02/01/17].
    30. Hubbard RA, Ripping TM, Chubak J, Broeders MJ, Miglioretti DL. Statistical Methods for Estimating the Cumulative Risk of Screening Mammography Outcomes. Cancer Epidemiol Biomarkers Prev. 2016 Mar; 25(3):513-20. PMID: 26721668; PMCID: PMC4779749 [Available on 03/01/17].
    31. Chubak J, Hawkes R. Animal-Assisted Activities: Results From a Survey of Top-Ranked Pediatric Oncology Hospitals. J Pediatr Oncol Nurs. 2016 07; 33(4):289-96. PMID: 26589356; PMCID: PMC4874916 [Available on 07/01/17].
    32. Kroenke CH, Chubak J, Johnson L, Castillo A, Weltzien E, Caan BJ. Enhancing Breast Cancer Recurrence Algorithms Through Selective Use of Medical Record Data. J Natl Cancer Inst. 2016 Mar; 108(3). PMID: 26582243.
      View in: PubMed
    33. Chubak J, Bowles EJ, Yu O, Buist DS, Fujii M, Boudreau DM. Breast cancer recurrence in relation to antidepressant use. Cancer Causes Control. 2016 Jan; 27(1):125-36. PMID: 26518198; PMCID: PMC4913547.
    34. Green BB, Anderson ML, Chubak J, Fuller S, Meenan RT, Vernon SW. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial. Cancer. 2016 Jan 15; 122(2):312-21. PMID: 26488332; PMCID: PMC4868396.
    35. Jones SM, Ziebell R, Walker R, Nekhlyudov L, Rabin BA, Nutt S, Fujii M, Chubak J. Psychometric investigation of benefit finding among long-term cancer survivors using the Medical Expenditure Panel Survey. Eur J Oncol Nurs. 2016 Feb; 20:31-5. PMID: 26220893.
      View in: PubMed
    36. Meenan RT, Anderson ML, Chubak J, Vernon SW, Fuller S, Wang CY, Green BB. An economic evaluation of colorectal cancer screening in primary care practice. Am J Prev Med. 2015 Jun; 48(6):714-21. PMID: 25998922; PMCID: PMC4441758.
    37. Adams KF, Johnson EA, Chubak J, Kamineni A, Doubeni CA, Buist DS, Williams AE, Weinmann S, Doria-Rose VP, Rutter CM. Development of an Algorithm to Classify Colonoscopy Indication from Coded Health Care Data. EGEMS (Wash DC). 2015; 3(1):1171. PMID: 26290883.
      View in: PubMed
    38. Ludman EJ, McCorkle R, Bowles EA, Rutter CM, Chubak J, Tuzzio L, Jones S, Reid RJ, Penfold R, Wagner EH. Do depressed newly diagnosed cancer patients differentially benefit from nurse navigation? Gen Hosp Psychiatry. 2015 May-Jun; 37(3):236-9. PMID: 25835508; PMCID: PMC4442728.
    39. Chubak J, Hubbard RA, Johnson E, Kamineni A, Rutter CM. Assessing the effectiveness of a cancer screening test in the presence of another screening modality. J Med Screen. 2015 Jun; 22(2):69-75. PMID: 25492942; PMCID: PMC4431895.
    40. Hubbard R, Chubak J, Rutter C. Estimating screening test utilization using electronic health records data. EGEMS (Wash DC). 2014 Nov 04; 2(1):14. PMID: 25741527.
      View in: PubMed
    41. Andersen MR, Thorpe J, Buist DS, Beatty JD, Watabayashi K, Hanson N, Resta R, Chubak J, Urban N. Cancer Risk Awareness and Concern among Women with a Family History of Breast or Ovarian Cancer. Behav Med. 2016; 42(1):18-28. PMID: 25062114; PMCID: PMC4469617.
    42. Green BB, Anderson ML, Wang CY, Vernon SW, Chubak J, Meenan RT, Fuller S. Results of nurse navigator follow-up after positive colorectal cancer screening test: a randomized trial. J Am Board Fam Med. 2014 Nov-Dec; 27(6):789-95. PMID: 25381076; PMCID: PMC4278960.
    43. Murphy CC, Vernon SW, Haddock NM, Anderson ML, Chubak J, Green BB. Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial. Prev Med. 2014 Sep; 66:123-30. PMID: 24937648; PMCID: PMC4209306.
    44. Tiro JA, Kamineni A, Levin TR, Zheng Y, Schottinger JS, Rutter CM, Corley DA, Skinner CS, Chubak J, Doubeni CA, Halm EA, Gupta S, Wernli KJ, Klabunde C. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1147-58. PMID: 24917182; PMCID: PMC4148641.
    45. Wang CY, de Dieu Tapsoba J, Anderson ML, Vernon SW, Chubak J, Fuller S, Green BB. Time to screening in the systems of support to increase colorectal cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2014 Aug; 23(8):1683-8. PMID: 24891548; PMCID: PMC4119537.
    46. Wernli KJ, Hubbard RA, Johnson E, Chubak J, Kamineni A, Green BB, Rutter CM. Patterns of colorectal cancer screening uptake in newly eligible men and women. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1230-7. PMID: 24793956; PMCID: PMC4082473.
    47. Boudreau DM, Yu O, Chubak J, Wirtz HS, Bowles EJ, Fujii M, Buist DS. Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer. Breast Cancer Res Treat. 2014 Apr; 144(2):405-16. PMID: 24557337; PMCID: PMC3988288.
    48. Carrell DS, Halgrim S, Tran DT, Buist DS, Chubak J, Chapman WW, Savova G. Carrell et al. respond to "Observational research and the EHR". Am J Epidemiol. 2014 Mar 15; 179(6):762-3. PMID: 24488509; PMCID: PMC4081638.
    49. Carrell DS, Halgrim S, Tran DT, Buist DS, Chubak J, Chapman WW, Savova G. Using natural language processing to improve efficiency of manual chart abstraction in research: the case of breast cancer recurrence. Am J Epidemiol. 2014 Mar 15; 179(6):749-58. PMID: 24488511; PMCID: PMC3939853.
    50. Chubak J, Aiello Bowles EJ, Tuzzio L, Ludman E, Rutter CM, Reid RJ, Wagner EH. Perspectives of cancer survivors on the role of different healthcare providers in an integrated delivery system. J Cancer Surviv. 2014 Jun; 8(2):229-38. PMID: 24352871; PMCID: PMC4016186.
    51. Wagner EH, Ludman EJ, Aiello Bowles EJ, Penfold R, Reid RJ, Rutter CM, Chubak J, McCorkle R. Nurse navigators in early cancer care: a randomized, controlled trial. J Clin Oncol. 2014 Jan 01; 32(1):12-8. PMID: 24276777; PMCID: PMC3867643.
    52. Laing SS, Bogart A, Chubak J, Fuller S, Green BB. Psychological distress after a positive fecal occult blood test result among members of an integrated healthcare delivery system. Cancer Epidemiol Biomarkers Prev. 2014 Jan; 23(1):154-9. PMID: 24220914; PMCID: PMC3947142.
    53. Hamilton JG, Birmingham WC, Tehranifar P, Irwin ML, Klein WM, Nebeling L, Chubak J. Transitioning to independence and maintaining research careers in a new funding climate: american society of preventive oncology junior members interest group report. Cancer Epidemiol Biomarkers Prev. 2013 Nov; 22(11):2138-42. PMID: 24190867.
      View in: PubMed
    54. Chubak J, Bogart A, Fuller S, Laing SS, Green BB. Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial. Prev Med. 2013 Nov; 57(5):671-8. PMID: 24029556; PMCID: PMC3856243.
    55. Chubak J, Boudreau DM, Wirtz HS, McKnight B, Weiss NS. Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival. J Natl Cancer Inst. 2013 Oct 02; 105(19):1456-62. PMID: 23940288; PMCID: PMC3787908.
    56. Perdue DG, Chubak J, Bogart A, Dillard DA, Garroutte EM, Buchwald D. A comparison of colorectal cancer screening uptake among average-risk insured American Indian/Alaska Native and white women. J Health Care Poor Underserved. 2013 Aug; 24(3):1125-35. PMID: 23974386.
      View in: PubMed
    57. Wirtz HS, Buist DS, Gralow JR, Barlow WE, Gray S, Chubak J, Yu O, Bowles EJ, Fujii M, Boudreau DM. Frequent antibiotic use and second breast cancer events. Cancer Epidemiol Biomarkers Prev. 2013 Sep; 22(9):1588-99. PMID: 23833124; PMCID: PMC3769442.
    58. Chubak J, Yu O, Buist DS, Wirtz HS, Boudreau DM. Time scale in follow-up studies: considering disease prognosis. Epidemiology. 2013 Jul; 24(4):628-9. PMID: 23732747; PMCID: PMC3860321.
    59. Lowry SJ, Chubak J, Press OW, McKnight B, Weiss NS. Risk of non-Hodgkin lymphoma in relation to tricyclic antidepressant use. Ann Epidemiol. 2013 Jun; 23(6):349-54. PMID: 23683711; PMCID: PMC3718633.
    60. Chubak J, Rutter CM, Kamineni A, Johnson EA, Stout NK, Weiss NS, Doria-Rose VP, Doubeni CA, Buist DS. Measurement in comparative effectiveness research. Am J Prev Med. 2013 May; 44(5):513-9. PMID: 23597816; PMCID: PMC3631525.
    61. Green BB, Wang CY, Anderson ML, Chubak J, Meenan RT, Vernon SW, Fuller S. An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):301-11. PMID: 23460053; PMCID: PMC3953144.
    62. Doubeni CA, Weinmann S, Adams K, Kamineni A, Buist DS, Ash AS, Rutter CM, Doria-Rose VP, Corley DA, Greenlee RT, Chubak J, Williams A, Kroll-Desrosiers AR, Johnson E, Webster J, Richert-Boe K, Levin TR, Fletcher RH, Weiss NS. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):312-20. PMID: 23460054; PMCID: PMC3752391.
    63. Nekhlyudov L, Greene SM, Chubak J, Rabin B, Tuzzio L, Rolnick S, Field TS. Cancer research network: using integrated healthcare delivery systems as platforms for cancer survivorship research. J Cancer Surviv. 2013 Mar; 7(1):55-62. PMID: 23239136.
      View in: PubMed
    64. Chubak J. What can epidemiology contribute to comparative effectiveness research? J Epidemiol Community Health. 2013 Mar; 67(3):206-7. PMID: 23180807.
      View in: PubMed
    65. Henderson JA, Chubak J, O'Connell J, Ramos MC, Jensen J, Jobe JB. Design of a randomized controlled trial of a web-based intervention to reduce cardiovascular disease risk factors among remote reservation-dwelling American Indian adults with type 2 diabetes. J Prim Prev. 2012 Aug; 33(4):209-22. PMID: 23001642; PMCID: PMC4539001.
    66. Aiello Bowles EJ, Boudreau DM, Chubak J, Yu O, Fujii M, Chestnut J, Buist DS. Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer. J Oncol Pract. 2012 Nov; 8(6):e149-57. PMID: 23598850; PMCID: PMC3500489.
    67. Chubak J, Anderson ML, Saunders KW, Hubbard RA, Tuzzio L, Liss DT, Morales LS, Reid RJ. Predictors of 1-year change in patient activation in older adults with diabetes mellitus and heart disease. J Am Geriatr Soc. 2012 Jul; 60(7):1316-21. PMID: 22788389.
      View in: PubMed
    68. Pocobelli G, Chubak J, Hanson N, Drescher C, Resta R, Urban N, Buist DS. Prophylactic oophorectomy rates in relation to a guideline update on referral to genetic counseling. Gynecol Oncol. 2012 Aug; 126(2):229-35. PMID: 22564716; PMCID: PMC3383401.
    69. Chubak J, Yu O, Pocobelli G, Lamerato L, Webster J, Prout MN, Ulcickas Yood M, Barlow WE, Buist DS. Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer. J Natl Cancer Inst. 2012 Jun 20; 104(12):931-40. PMID: 22547340; PMCID: PMC3732250.
    70. Green BB, Bogart A, Chubak J, Vernon SW, Morales LS, Meenan RT, Laing SS, Fuller S, Ko C, Wang CY. Nonparticipation in a population-based trial to increase colorectal cancer screening. Am J Prev Med. 2012 Apr; 42(4):390-7. PMID: 22424252; PMCID: PMC3549634.
    71. Bowles EJ, Buist DS, Chubak J, Yu O, Johnson J, Chestnut J, Boudreau DM. Endocrine therapy initiation from 2001 to 2008 varies by age at breast cancer diagnosis and tumor size. J Oncol Pract. 2012 Mar; 8(2):113-20. PMID: 23077439; PMCID: PMC3457815.
    72. Chubak J, Tuzzio L, Hsu C, Alfano CM, Rabin BA, Hornbrook MC, Spegman A, Von Worley A, Williams A, Nekhlyudov L. Providing care for cancer survivors in integrated health care delivery systems: practices, challenges, and research opportunities. J Oncol Pract. 2012 May; 8(3):184-9. PMID: 22942814; PMCID: PMC3396808.
    73. Chubak J, Pocobelli G, Weiss NS. Tradeoffs between accuracy measures for electronic health care data algorithms. J Clin Epidemiol. 2012 Mar; 65(3):343-349.e2. PMID: 22197520; PMCID: PMC3264740.
    74. Liss DT, Chubak J, Anderson ML, Saunders KW, Tuzzio L, Reid RJ. Patient-reported care coordination: associations with primary care continuity and specialty care use. Ann Fam Med. 2011 Jul-Aug; 9(4):323-9. PMID: 21747103; PMCID: PMC3133579.
    75. Chubak J, Boudreau DM, Rulyak SJ, Mandelson MT. Colorectal cancer risk in relation to antidepressant medication use. Int J Cancer. 2011 Jan 01; 128(1):227-32. PMID: 20232382; PMCID: PMC2962879.
    76. Chubak J, Boudreau DM, Fishman PA, Elmore JG. Cost of breast-related care in the year following false positive screening mammograms. Med Care. 2010 Sep; 48(9):815-20. PMID: 20706161; PMCID: PMC3079487.
    77. Green BB, Wang CY, Horner K, Catz S, Meenan RT, Vernon SW, Carrell D, Chubak J, Ko C, Laing S, Bogart A. Systems of support to increase colorectal cancer screening and follow-up rates (SOS): design, challenges, and baseline characteristics of trial participants. Contemp Clin Trials. 2010 Nov; 31(6):589-603. PMID: 20674774; PMCID: PMC2956868.
    78. Buist DS, Chubak J, Prout M, Yood MU, Bosco JL, Thwin SS, Gold HT, Owusu C, Field TS, Quinn VP, Wei F, Silliman RA. Referral, receipt, and completion of chemotherapy in patients with early-stage breast cancer older than 65 years and at high risk of breast cancer recurrence. J Clin Oncol. 2009 Sep 20; 27(27):4508-14. PMID: 19687341; PMCID: PMC2754903.
    79. Hudson SV, Chubak J, Coups EJ, Blake-Gumbs L, Jacobsen PB, Neugut AI, Buist DS. Identifying key questions to advance research and practice in cancer survivorship follow-up care: a report from the ASPO Survivorship Interest Group. Cancer Epidemiol Biomarkers Prev. 2009 Jul; 18(7):2152-4. PMID: 19589917; PMCID: PMC4285698.
    80. Chubak J, Boudreau DM, Rulyak SJ, Mandelson MT. Colorectal cancer risk in relation to use of acid suppressive medications. Pharmacoepidemiol Drug Saf. 2009 Jul; 18(7):540-4. PMID: 19367565; PMCID: PMC3690626.
    81. Chubak J, Bowles EJ, Terry MB, Trentham-Dietz A, Buist DS. Antidepressant medications and change in mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2009 Feb; 18(2):676-9. PMID: 19190163; PMCID: PMC2640441.
    82. Hawkins VN, Foster-Schubert K, Chubak J, Sorensen B, Ulrich CM, Stancyzk FZ, Plymate S, Stanford J, White E, Potter JD, McTiernan A. Effect of exercise on serum sex hormones in men: a 12-month randomized clinical trial. Med Sci Sports Exerc. 2008 Feb; 40(2):223-33. PMID: 18202581; PMCID: PMC3040039.
    83. Chubak J, Buist DS, Boudreau DM, Rossing MA, Lumley T, Weiss NS. Breast cancer recurrence risk in relation to antidepressant use after diagnosis. Breast Cancer Res Treat. 2008 Nov; 112(1):123-32. PMID: 18058227; PMCID: PMC3519424.
    84. Chubak J, Doherty JA, Cushing-Haugen KL, Voigt LF, Saltzman BS, Hill DA, Beresford SA, Weiss NS. Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy. Cancer Causes Control. 2007 Nov; 18(9):1001-7. PMID: 17653829.
      View in: PubMed
    85. Tworoger SS, Sorensen B, Chubak J, Irwin M, Stanczyk FZ, Ulrich CM, Potter J, McTiernan A. Effect of a 12-month randomized clinical trial of exercise on serum prolactin concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2007 May; 16(5):895-9. PMID: 17507612.
      View in: PubMed
    86. Rhew I, Yasui Y, Sorensen B, Ulrich CM, Neuhouser ML, Tworoger SS, Chubak J, Bowen DJ, McTiernan A. Effects of an exercise intervention on other health behaviors in overweight/obese post-menopausal women. Contemp Clin Trials. 2007 Jul; 28(4):472-81. PMID: 17287149.
      View in: PubMed
    87. Chubak J, McTiernan A, Sorensen B, Wener MH, Yasui Y, Velasquez M, Wood B, Rajan KB, Wetmore CM, Potter JD, Ulrich CM. Moderate-intensity exercise reduces the incidence of colds among postmenopausal women. Am J Med. 2006 Nov; 119(11):937-42. PMID: 17071161.
      View in: PubMed
    88. Chubak J, Ulrich CM, Tworoger SS, Sorensen B, Yasui Y, Irwin ML, Stanczyk FZ, Potter JD, McTiernan A. Effect of exercise on bone mineral density and lean mass in postmenopausal women. Med Sci Sports Exerc. 2006 Jul; 38(7):1236-44. PMID: 16826020.
      View in: PubMed
    89. Mohanka M, Irwin M, Heckbert SR, Yasui Y, Sorensen B, Chubak J, Tworoger SS, Ulrich CM, McTiernan A. Serum lipoproteins in overweight/obese postmenopausal women: a one-year exercise trial. Med Sci Sports Exerc. 2006 Feb; 38(2):231-9. PMID: 16531889.
      View in: PubMed
    90. Chubak J, Tworoger SS, Yasui Y, Ulrich CM, Stanczyk FZ, McTiernan A. Associations between reproductive and menstrual factors and postmenopausal androgen concentrations. J Womens Health (Larchmt). 2005 Oct; 14(8):704-12. PMID: 16232102.
      View in: PubMed
    91. Chubak J, Tworoger SS, Yasui Y, Ulrich CM, Stanczyk FZ, McTiernan A. Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations. Cancer Epidemiol Biomarkers Prev. 2004 Aug; 13(8):1296-301. PMID: 15298949.
      View in: PubMed
    92. McTiernan A, Tworoger SS, Rajan KB, Yasui Y, Sorenson B, Ulrich CM, Chubak J, Stanczyk FZ, Bowen D, Irwin ML, Rudolph RE, Potter JD, Schwartz RS. Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2004 Jul; 13(7):1099-105. PMID: 15247119.
      View in: PubMed
    93. Tworoger SS, Chubak J, Aiello EJ, Yasui Y, Ulrich CM, Farin FM, Stapleton PL, Irwin ML, Potter JD, Schwartz RS, McTiernan A. The effect of CYP19 and COMT polymorphisms on exercise-induced fat loss in postmenopausal women. Obes Res. 2004 Jun; 12(6):972-81. PMID: 15229337.
      View in: PubMed
    94. Tworoger SS, Chubak J, Aiello EJ, Ulrich CM, Atkinson C, Potter JD, Yasui Y, Stapleton PL, Lampe JW, Farin FM, Stanczyk FZ, McTiernan A. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2004 Jan; 13(1):94-101. PMID: 14744739.
      View in: PubMed
    Chubak's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    © 2019 Kaiser Permanente

    KP Researcher Profiles is funded by Kaiser Permanente Research.